PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier
Abstract Background Nanocarriers targeting the blood-brain barrier (BBB) are promising drug delivery systems to enhance the penetration of therapeutic molecules into the brain. Immunotherapy, particularly monoclonal antibodies designed to bind amyloid-beta peptides have become a promising strategy f...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2025-04-01
|
| Series: | Fluids and Barriers of the CNS |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12987-025-00641-0 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|